Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation.

MLA

Sadeghi, Samar, et al. “Potency Assay to Predict the Anti-Inflammatory Capacity of a Cell Therapy Product for Macrophage-Driven Diseases: Overcoming the Challenges of Assay Development and Validation.” Cytotherapy, vol. 26, no. 5, May 2024, pp. 512–23. EBSCOhost, https://doi.org/10.1016/j.jcyt.2024.02.004.

APA

Sadeghi, S., Nimtz, L., Niebergall-Roth, E., Norrick, A., Hägele, S., Vollmer, L., Esterlechner, J., Frank, M. H., Ganss, C., Scharffetter-Kochanek, K., & Kluth, M. A. (2024). Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation. Cytotherapy, 26(5), 512–523. https://doi.org/10.1016/j.jcyt.2024.02.004

Chicago

Sadeghi, Samar, Laura Nimtz, Elke Niebergall-Roth, Alexandra Norrick, Stefan Hägele, Lena Vollmer, Jasmina Esterlechner, et al. 2024. “Potency Assay to Predict the Anti-Inflammatory Capacity of a Cell Therapy Product for Macrophage-Driven Diseases: Overcoming the Challenges of Assay Development and Validation.” Cytotherapy 26 (5): 512–23. doi:10.1016/j.jcyt.2024.02.004.